VALENCIA, Calif., Dec. 7, 2015 (GLOBE NEWSWIRE) — Envoy Group Corp. (OTC:ENVV) is pleased to announce the company has signed an an agreement with BVD Ltd. for exclusive distribution rights for the Louis XIV Energy Drinks within Canada.
The Louis XIV Brand is a premier energy drink. Currently only available in Europe, Louis XIV has developed revolutionary, unique and vibrant energy drinks. The drinks’ full-bodied citric base stands alone as a perfect refresher and is an inspired complimentary mixer in European nightclubs.
Louis XIV Energy Drinks have exploded onto Europe’s cultural and nightlife experience. Louis XIV has been an enthusiastic sponsor of many development and lifestyle events including being the official energy drink supplier for Google at Europe’s largest developer conference: EuroPython 2015. Louis XIV also sponsored the 2014 London Lifestyle Awards, which highlight the very best in business and places in the iconic city. Louis XIV was also the sponsor of the Mockingjay Hunger Games Premiere VIP party in London. The company’s stylish drink design has already won an international design award and was one of the top three finalists for Best Can from the World Beverage Innovation Awards.
Envoy’s CEO, Harp Sangha commented “We are delighted to be bringing the Louis XIV Energy Drink line and lifestyle to Canada. I have personally introduced the Louis XIV product line to several high end marketing and retail clients and have had only rave revues for all aspects of this unique product.”
Envoy Group is planning a comprehensive, strategic marketing and distribution campaign for the energy drink that will greatly appeal to the high end market across the Canada. The product roll out will commence as soon as import regulatory measures are met.
Envoy will not be proceeding with its acquisition of Picante Gaming. The principals of Picante have elected to keep the company private.
For further information please visit our website at: www.envoygroupcorp.com
Louis XIV website link: http://www.louisxivenergy.com/en/
Safe Harbor Statements
Certain information contained in this news release constitutes “forward-looking statements” as such term is used in applicable United States and Canadian laws. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “expects” or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “estimates”, “intends” or “believes”, or that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur”, or “be achieved”. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made, and are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. Many of these factors are beyond the Company’s ability to control or predict. Important factors that may cause actual results to differ materially and that could impact the Company and the statements contained in this news release can be found in the Company’s filings with the SEC. Such risks and other factors include, among others, the ability to locate and acquire suitable interests in alternative medicine manufacturing operations on terms acceptable to the Company, the availability of financing on acceptable terms, accidents, labor disputes, acts of God and other risks of the alternative medicine industry including, without limitation, delays in obtaining governmental approvals or permits, title disputes or claims limitations on insurance coverage. The Company believes that the expectations reflected in the forward-looking statements included in this news release are reasonable; however, no assurance can be given that these expectations will prove to be correct, and such forward-looking statements should not be unduly relied upon. The Company assumes no obligation to update or supplement any forward-looking statements whether as a result of new information, future events or otherwise.
CONTACT: Investor Relations: Teso Communications www.tesocommunications.com 1-888-648-0488 Harp Sangha Chairman/CEO Tel: 1-604-825-1309 Email: [email protected]